• Laboratory: Hilma Biocare
  • Form: Oral
  • Molecule: Tamoxifen Citrate
  • Concentration: 20mg / tabs
  • Presentation: 50 Tabs
  • Recommended dosage: 20mg / day

More details

This product is no longer in stock

Price:25,00 €

More info

Use and effective range:

Applications: Estrogen receptor blocker, post-cycle therapy, against gynecomastia

Anabolic components: not exist

Androgenic components: not exist


Dose range and duration of use:

Beginners: 10-40mg / day

Hobby: 10-40mg / day

Professional range: 20-80mg / day

Women: 10-40mg / day

Application period: 2-16 weeks

Active-Life: Less than 24 hours

Drug Class: Estrogen-Agonist/-Antagonist (Oral)

Average Reported Dosage: 10-80-mg daily

Acne: None

Water Retention: No

High Blood Pressure: Rare (not normally attributed to the drug itself)

Liver Toxic: Yes

Tamoxifen Citrate is a drug commonly referred to as an anti-estrogen. This would suggest less or no estrogen is produced due to the drug’s actions as in the case of Teslac. Actually, Tamoxifen Citrate is an estrogen antagonist, meaning it competes with estrogen at estrogen receptor- sites. This prevents the active estrogen from entering its receptor and creating an estrogenic complex capable of activity. Since many AAS aromatize (covert to estrogen) to some degree, the control of feminizing side effects (males should pay attention here) is important. Males normally have a very low estrogen level.

During AAS cycles, due to aromatization, estrogen levels rise considerably. This elevated estrogen level can cause feminizing side effects such as increased fat deposits, water retention, and gynecomastia (growth of breast gland tissue and painful tumors under the nipple). As a rule, it is more the ratio of androgens-to-estrogens than the simple increase in estrogen that actually initiates feminizing side effects.